Back
Lonza Group Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
38
LZAGF
Lonza Group
Last Price:
637.00
Seasonality Move:
4.22%
Buy
56
CRSP
CRISPR Therapeutics AG
Last Price:
50.76
Seasonality Move:
35.78%
Sell
38
Lonza Group (LZAGF)
is a Sell
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGF] share price is $637.00. The Score for LZAGF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- LZAGF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $50.76. The Score for CRSP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LZAGF Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $637.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LZAGF is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $50.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
LZAGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.07 | Sell |
| Relative Strength Index (14 RSI): | 52.73 | Buy |
| Chaikin Money Flow: | 33 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (606.41 - 641.79) | Buy |
| Bollinger Bands (100): | (571.57 - 656.03) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 59.39 | Buy |
| Chaikin Money Flow: | 2128956 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.6 - 48.76) | Buy |
| Bollinger Bands (100): | (45.7 - 56.42) | Sell |
LZAGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 627.91 | Buy |
| 20-day SMA: | 621.11 | Buy |
| 50-day SMA: | 633.23 | Buy |
| 200-day SMA: | 579.18 | Buy |
| 8-day EMA: | 625.07 | Buy |
| 20-day EMA: | 625.68 | Buy |
| 50-day EMA: | 625.87 | Buy |
| 200-day EMA: | 585.49 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.13 | Buy |
| 20-day SMA: | 47.45 | Buy |
| 50-day SMA: | 47.16 | Buy |
| 200-day SMA: | 58.25 | Sell |
| 8-day EMA: | 48.42 | Buy |
| 20-day EMA: | 47.83 | Buy |
| 50-day EMA: | 48.23 | Buy |
| 200-day EMA: | 53.92 | Sell |
Lonza Group Earnings Growth & LZAGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.69 per share, and an increase next year of $0.35 per share.
Lonza Group Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||